Back to top

Trial used to approve Amgen’s Tavneos retracted from NEJM

A clinical trial, originally published in 2021, which was used to approve Amgen’s (AMGN) Tavneos was retracted Monday from the New England Journal ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Affiliated Managers Group, Inc. (AMG)

Amgen Inc. (AMGN)